
BIO KEY INTERNATIONAL INC
84
Recent developments include the release of Q3 2026 earnings call transcripts and news reports highlighting a quarterly loss and revenue below expectations.
- BIO-key released its Q3 2026 earnings call transcript providing insights into operational and financial performance [N1].
- The company reported a net loss and revenue below prior expectations for Q3 2026 [N2].
- A Q2 2026 earnings call transcript was also published earlier in the year, offering additional context on company operations [N7].
BIO-key International Inc. is a technology company listed on the Nasdaq Capital Market under the ticker BKYI. The company completed a reverse stock split in April 2026, adjusting its shares outstanding to about 2 million. It operates across multiple regions including North America, Africa, EMESA, and Asia. The latest SEC filings provide detailed financial data through Q3 2026, showing the company maintains liquidity with a current ratio above 2. The company reported a net loss for the nine months ended September 30, 2026, with basic earnings per share of -$4.01. Recent earnings call transcripts and news reports provide additional context on its operational and financial performance.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. BIO-key International Inc. reported a net loss of approximately $886,000 for the nine months ended September 30, 2026, with liquidity ratios indicating a current ratio of 2.47 and a cash ratio of 1.04 as of that date [S2]. Recent news includes Q3 2026 earnings call transcripts and reports of a quarterly loss and revenue below prior expectations [N1][N2].
The company maintains liquidity with a current ratio of 2.47 and cash ratio above 1, indicating an ability to meet short-term obligations. Its operations across diverse regions may provide multiple revenue streams. Recent earnings calls offer transparency into business operations, which supports investor understanding of company strategy and execution.
BIO-key reported a net loss for the nine months ended September 30, 2026, with negative earnings per share, indicating ongoing profitability challenges. Revenue for Q3 2026 was reported below prior expectations. The company’s relatively small share count post-reverse split may reflect limited market capitalization and liquidity. Lack of detailed disclosure on competitive positioning and product differentiation may limit visibility into long-term sustainability.
BIO-key International Inc. operates in the biometric technology sector, which typically involves specialized intellectual property and technology solutions. The company's presence across multiple geographic regions suggests a diversified market approach. However, specific details on proprietary technology, customer contracts, or competitive advantages are not explicitly disclosed in the available filings and news.
• Profitability Risk: The company reported a net loss and negative earnings per share for the nine months ended September 30, 2026, indicating ongoing challenges in achieving profitability.
• Revenue Performance Risk: Recent news reports indicate Q3 2026 revenue lagged prior expectations, suggesting potential challenges in sales growth or market demand.
• Liquidity and Capital Structure Risk: While liquidity ratios are currently adequate, the company’s small cash balance and limited market capitalization post-reverse stock split may constrain financial flexibility.
• Limited Disclosure on Competitive Position: There is limited public information on the company’s proprietary technology, customer base, or competitive moat, which may affect visibility into future business sustainability.
Business trends: The company continues to operate across multiple regions with ongoing revenue generation but reports net losses and revenue shortfalls.
Execution milestones: Recent quarterly earnings calls and SEC filings provide transparency into financial performance and liquidity status.
Key risks: Profitability challenges, revenue performance variability, limited disclosure on competitive positioning, and financial flexibility constraints.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- BIO-key International Inc. is a publicly traded company on the Nasdaq Capital Market under the ticker BKYI.
- The company filed a 10-Q quarterly report for the period ended September 30, 2026, on November 13, 2026 [S2].
- As of September 30, 2026, BIO-key had cash and cash equivalents of approximately $2.22 million and current assets totaling about $5.28 million, with current liabilities of approximately $2.14 million, resulting in a current ratio of 2.47 and a cash ratio of 1.04, indicating liquidity coverage [S2].
- The company reported a net loss of approximately $886,000 for the nine months ended September 30, 2026, with basic earnings per share of -$4.01 for the same period [S2].
- BIO-key completed a 1-for-10 reverse stock split effective April 30, 2026, adjusting its shares outstanding to approximately 2.04 million as of November 12, 2026 [S2].
- The company operates in multiple geographic regions including North America, Africa, EMESA (Europe, Middle East, South America), and Asia as indicated in SEC filings [S2].
- Recent earnings call transcripts for Q2 and Q3 2026 provide insights into the company's operational and financial performance [N1][N7].
- News reports indicate BIO-key reported a Q3 2026 loss and revenue below prior expectations [N2].
Generated 2026-11-14
- S1 | 2026-06-12 | 10-K/A
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-11-13 | www.nasdaq.com | BIO-key (BKYI) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/bio-key-bkyi-q3-2026-earnings-call-transcript
- N2 | 2026-11-13 | www.nasdaq.com | BIO-key International Inc. (BKYI) Reports Q3 Loss, Lags Revenue Estimates | https://www.nasdaq.com/articles/bio-key-international-inc-bkyi-reports-q3-loss-lags-revenue-estimates
- N3 | 2026-11-12 | www.nasdaq.com | Dragonfly Energy Holdings Corp. (DFLI) Reports Q3 Loss, Misses Revenue Estimates | https://www.nasdaq.com/articles/dragonfly-energy-holdings-corp-dfli-reports-q3-loss-misses-revenue-estimates
- N4 | 2026-11-05 | www.nasdaq.com | Rockwell Automation (ROK) Surpasses Q4 Earnings Estimates | https://www.nasdaq.com/articles/rockwell-automation-rok-surpasses-q4-earnings-estimates
- N5 | 2026-11-04 | www.nasdaq.com | Power Integrations (POWI) Q3 Earnings Surpass Estimates | https://www.nasdaq.com/articles/power-integrations-powi-q3-earnings-surpass-estimates
- N6 | 2026-10-28 | www.nasdaq.com | Hayward Holdings, Inc. (HAYW) Q3 Earnings and Revenues Beat Estimates | https://www.nasdaq.com/articles/hayward-holdings-inc-hayw-q3-earnings-and-revenues-beat-estimates
- N7 | 2026-08-21 | www.nasdaq.com | BIO-key (BKYI) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/bio-key-bkyi-q2-2026-earnings-call-transcript
- N8 | 2026-06-22 | www.nasdaq.com | Stocks Erase Early Gains as Alphabet and Software Companies Fall | https://www.nasdaq.com/articles/stocks-erase-early-gains-alphabet-and-software-companies-fall
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


